The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional protein-based coronavirus ...

Novavax's vaccine targets the highly contagious omicron subvariant JN.1, which began circulating widely in the U.S. earlier this year. JN.1 only accounted for 0.2% of cases circulating nationwide as ...

The Food and Drug Administration (FDA) signed off Wednesday on an emergency use authorization for the Novavax COVID-19 vaccine for individuals 18 years of age and older. The Novavax vaccine is protein ...

A more traditional kind of COVID-19 vaccine has moved a step closer to the U.S. market. Advisers to the Food and Drug Administration voted Tuesday to back shots made by Novavax for U.S. adults. If the ...

We recently compiled a list of the 11 Cheap Biotech Stocks to Buy According to Hedge Funds. Novavax, Inc. is one of them. Novavax, Inc. (NASDAQ:NVAX) is a biotechnology company specializing in ...

Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the third quarter ended ...

There may soon be another COVID-19 vaccine on the market in the U.S. Novavax announced Monday that it has submitted a request to the Food and Drug Administration for emergency use authorization for ...

Sara: Welcome to February. We have officially made it through the first month of 2022 — which, at least from where I sit, felt like a few months in one. (Is it just me?) We’re getting closer to Inno ...

The move would add another barrier for parents who want to vaccinate healthy children ahead of the respiratory virus season.